Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 180

1.

Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.

Zheng Y, Yu T, Tang Y, Xiong W, Shen X, Jiang L, Lin L.

PLoS One. 2017 Mar 14;12(3):e0172846. doi: 10.1371/journal.pone.0172846. eCollection 2017 Mar 14.

2.

Efficacy of ondansetron for the prevention of propofol injection pain: a meta-analysis.

Pei S, Zhou C, Zhu Y, Huang B.

J Pain Res. 2017 Feb 21;10:445-450. doi: 10.2147/JPR.S128992. eCollection 2017 Feb 21.

3.

Dietary and pharmacological treatment of abdominal pain in IBS.

Camilleri M, Boeckxstaens G.

Gut. 2017 Feb 23. pii: gutjnl-2016-313425. doi: 10.1136/gutjnl-2016-313425. [Epub ahead of print] Review.

PMID:
28232472
4.

Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity.

Cservenka A, Yardley MM, Ray LA.

Am J Addict. 2016 Nov 4. doi: 10.1111/ajad.12463. [Epub ahead of print]

PMID:
28134463
5.

Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis.

Tricco AC, Blondal E, Veroniki AA, Soobiah C, Vafaei A, Ivory J, Strifler L, Cardoso R, Reynen E, Nincic V, Ashoor H, Ho J, Ng C, Johnson C, Lillie E, Antony J, Roberts DJ, Hemmelgarn BR, Straus SE.

BMC Med. 2016 Dec 23;14(1):216. doi: 10.1186/s12916-016-0761-9.

6.

Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.

Soyka M, Kranzler HR, Hesselbrock V, Kasper S, Mutschler J, Möller HJ; WFSBP Task Force on Treatment Guidelines for Substance Use Disorders..

World J Biol Psychiatry. 2017 Mar;18(2):86-119. doi: 10.1080/15622975.2016.1246752. Epub 2016 Dec 23.

PMID:
28006997
7.

Publishing negative findings and the challenge of avoiding type II errors in studies of suspect teratogens: Example of a recent ondansetron publication.

Edlavitch SA.

Reprod Toxicol. 2017 Jan;67:125-128. doi: 10.1016/j.reprotox.2016.12.001. Epub 2016 Dec 15. Review.

PMID:
27988282
8.

[Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].

Rochoy M, Auffret M, Béné J, Gautier S; Réseau français des centres régionaux de pharmacovigilance..

Rev Epidemiol Sante Publique. 2017 Feb;65(1):1-8. doi: 10.1016/j.respe.2016.06.335. Epub 2016 Dec 14. French.

PMID:
27988172
9.

Aprepitant in pediatric patients using moderate and highly emetogenic protocols: a systematic review and meta-analyses of randomized controlled trials.

Okumura LM, D'Athayde Rodrigues F, Ferreira MA, Moreira LB.

Br J Clin Pharmacol. 2016 Nov 20. doi: 10.1111/bcp.13193. [Epub ahead of print]

PMID:
27868231
10.

Dexamethasone combined with other antiemetics versus single antiemetics for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: An updated systematic review and meta-analysis.

Awad K, Ahmed H, Abushouk AI, Al Nahrawi S, Elsherbeny MY, Mustafa SM, Attia A.

Int J Surg. 2016 Dec;36(Pt A):152-163. doi: 10.1016/j.ijsu.2016.10.034. Epub 2016 Oct 25. Review.

PMID:
27793640
11.

Meta-analysis of randomized controlled trials on the efficacy and safety of ondansetron in preventing postanesthesia shivering.

Li M, Hu X, Tan Y, Yang B, Li K, Tang Z.

Int J Surg. 2016 Nov;35:34-43. doi: 10.1016/j.ijsu.2016.09.009. Epub 2016 Sep 12. Review.

PMID:
27632391
12.

Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment.

O'Donnell A, McParlin C, Robson SC, Beyer F, Moloney E, Bryant A, Bradley J, Muirhead C, Nelson-Piercy C, Newbury-Birch D, Norman J, Simpson E, Swallow B, Yates L, Vale L.

Health Technol Assess. 2016 Oct;20(74):1-268.

13.

Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic Review.

McParlin C, O'Donnell A, Robson SC, Beyer F, Moloney E, Bryant A, Bradley J, Muirhead CR, Nelson-Piercy C, Newbury-Birch D, Norman J, Shaw C, Simpson E, Swallow B, Yates L, Vale L.

JAMA. 2016 Oct 4;316(13):1392-1401. doi: 10.1001/jama.2016.14337. Review.

PMID:
27701665
14.

Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.

Singh PM, Borle A, Gouda D, Makkar JK, Arora MK, Trikha A, Sinha A, Goudra B.

J Clin Anesth. 2016 Nov;34:459-82. doi: 10.1016/j.jclinane.2016.05.018. Epub 2016 Jun 28. Review.

PMID:
27687434
15.

[5-HT3-antagonists as a substitute for metoclopramide and domperidone: a literature review].

Mouch I, Brouwers JR, van 't Riet E, Nieboer P, Otten MH, Jansman FG.

Ned Tijdschr Geneeskd. 2016;160(0):A9887. Dutch.

PMID:
27677233
16.

Neurokinin-1 inhibitors in the prevention of nausea and vomiting from highly emetogenic chemotherapy: a network meta-analysis.

Abdel-Rahman O.

Ther Adv Med Oncol. 2016 Sep;8(5):396-406. doi: 10.1177/1758834016654902. Epub 2016 Jun 29. Review.

17.

2016 updated MASCC/ESMO consensus recommendations: Prevention of acute chemotherapy-induced nausea and vomiting in children.

Dupuis LL, Sung L, Molassiotis A, Orsey AD, Tissing W, van de Wetering M.

Support Care Cancer. 2017 Jan;25(1):323-331. Epub 2016 Aug 26.

PMID:
27565788
18.
19.

Ondansetron Use in Pregnancy andOndansetron Use in Pregnancy and Birth Defects: A Systematic Review.

Reichmann JP, Kirkbride MS.

Obstet Gynecol. 2016 Aug;128(2):409. doi: 10.1097/AOG.0000000000001548. No abstract available.

PMID:
27454720
20.

Systematic review with meta-analysis: ondansetron for vomiting in children with acute gastroenteritis.

Tomasik E, Ziółkowska E, Kołodziej M, Szajewska H.

Aliment Pharmacol Ther. 2016 Sep;44(5):438-46. doi: 10.1111/apt.13728. Epub 2016 Jul 11. Review.

PMID:
27401959

Supplemental Content

Loading ...
Support Center